MAP2K7 and neoplasm: Thus, AL530 is a novel, first-in-class aniline mustard “programed” to generate an inhibitor of MEK, or more simply an aniline mustard designed to be a MEK inhibitor strictly under hydrolytic conditions favored by the tumor microenvironment.